Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching Oracle’s 300-page disclosures for a simple answer—like how much cloud services & license support revenue grew—can take hours. Add in multiple segments, Autonomous Database metrics, and intricate share-repurchase notes, and Oracle’s SEC filings quickly become a maze for even seasoned analysts.
Stock Titan solves that problem in one place. Our AI reads every Oracle quarterly earnings report 10-Q filing, Oracle annual report 10-K simplified, and Oracle 8-K material events explained the moment they hit EDGAR, then delivers plain-English summaries, red-flag alerts, and context. Need Oracle insider trading Form 4 transactions? You’ll see Oracle Form 4 insider transactions real-time—with visualized buy/sell trends—before the market reacts. Wondering about Oracle proxy statement executive compensation? Our platform highlights CEO pay, option grants, and performance triggers in seconds.
Here’s how professionals use the page:
- Track Oracle executive stock transactions Form 4 to gauge insider sentiment.
- Compare cloud revenue and license margins across periods without opening spreadsheets.
- Export AI-curated key points from each Oracle earnings report filing analysis for quick stakeholder briefs.
- Receive push alerts when a new 8-K details major OCI outages or acquisition announcements.
Whether you’re understanding Oracle SEC documents with AI for the first time or you need granular footnote data fast, Stock Titan’s real-time updates and expert layer of interpretation turn complex Oracle paperwork into actionable insight.
Clayton M. Magouyrk, an officer of Oracle Corporation (ORCL), reported several transactions in mid-September 2025. On 09/12/2025 he sold 21,241 shares at $297.1077, reducing his direct holdings to 78,000 shares. On 09/15/2025 he was granted 61,452 restricted stock units (RSUs) that represent the right to receive one share each at settlement; those RSUs vest in four equal annual installments beginning one year after grant. The same day shows a disposition of 24,182 shares at $292.18, leaving 115,270 shares held directly after the reported transactions. Following the RSU grant, he beneficially owns 122,905 derivative shares related to outstanding RSUs.
This Form 144 notice relates to proposed sales of Common stock of the named issuer by an insider. The filing shows 16,323 shares offered through Fidelity Brokerage Services LLC with an aggregate market value of $5,118,892.80 and an approximate sale date of 09/16/2025 on the NYSE. The securities were acquired on 09/15/2025 via Restricted Stock Vesting and paid as Compensation. The filer also reported a prior sale on 08/05/2025 of 15,880 shares for gross proceeds of $4,041,142.40. The notice includes the required representation regarding absence of undisclosed material information.
Oracle Corp (ORCL) filed a Form 144 notifying of a proposed sale of 3,500 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $1,077,510 and approximately 2,841,714,000 shares outstanding. The notice lists acquisitions by the selling person as compensation: 3,303 shares acquired on 06/01/2023 and 4,866 shares acquired on 06/01/2022. The filer reports no sales in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
This Form 144 notice shows a proposed sale of 8,000 shares of common stock of Oracle Corporation (ORCL) through Wells Fargo Clearing Services, with an aggregate market value of $2,430,857 and an approximate sale date of 09/12/2025. The filer reports acquiring these shares on 05/31/2019 as grants and RSUs awarded by the issuer, with payment recorded on the acquisition date.
The filing also discloses a sale in the past three months: 3,500 shares sold on 09/12/2025 generating $1,071,000 in gross proceeds. Outstanding shares are listed as 2,841,714,000, indicating the proposed sale represents a de minimis percentage of the company's total shares.
Oracle insider filing a Form 144 notifies intent to sell 21,241 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $6,310,864.10 and an approximate sale date of 09/12/2025. The shares were acquired on 08/03/2025 upon restricted stock vesting as compensation. The filer also reported a prior sale of 15,000 shares on 06/17/2025 for gross proceeds of $3,211,483.72. The notice includes the standard attestation that no undisclosed material adverse information is known by the seller.
Oracle Corporation reports continuing strategic shifts toward cloud and software, with management expecting total cloud and software revenues to generally increase on a constant currency basis and the proportion of cloud revenues to rise. The company follows equity method accounting for its Ampere investment, with a carrying value of $1.7 billion as of August 31, 2025, and contingent put/call options to buy additional Ampere equity at prices of approximately $500 million to $1.5 billion through January 2027. SoftBank announced an agreement to acquire Ampere; Oracle will recognize its share of Ampere losses until that acquisition closes.
Oracle disclosed restructuring activity tied to employee severance, with $427 million recorded in other current liabilities and $73 million in other non-current liabilities as of August 31, 2025. The first-quarter effective tax rate reflected on adjusted measures was 20.5% versus 18.9% in the prior fiscal quarter measures. The filing reiterates revenue recognition practices: cloud revenues are typically billed in advance and recognized ratably; software license revenues are generally perpetual and recognized upfront.
Clayton M. Magouyrk, identified as an officer (President, OCI) of Oracle Corp (ORCL), reported transactions dated 08/04/2025 involving the vesting and disposition of restricted stock units and common stock. A grant of 62,500 restricted stock units settled on 08/04/2025 and resulted in 62,500 underlying shares; 62,500 shares were withheld to satisfy tax withholding. Separately, 23,981 shares were disposed at a reported price of $244.42. The filing shows reported beneficial ownership balances of 123,222 and 99,241 shares on the corresponding table lines.
The filing also corrects an omission: several RSU awards granted before Mr. Magouyrk became a Section 16 officer on June 2, 2025 were inadvertently omitted from his Form 3; the form discloses unvested RSU counts from prior grants (including 62,500, 176,186, 184,357, and 167,075). The filing records the tax-withholding method and provides vesting schedules for those prior grants.
Oracle Corp. (ORCL) – Form 4 insider activity for Michael D. Sicilia, President, Industries. On 4-5 Aug 2025 the officer reported several transactions:
- Dividend reinvestment: 183.329 shares acquired at $241.21.
- RSU exercise (Code M): 50,000 shares acquired at $0 cost.
- Tax withholding (Code F): 23,534 shares surrendered at $244.42.
- 10b5-1 sale (Code S): 15,880 shares sold at $254.48, ≈$4.0 million proceeds.
Direct ownership rises to 99,212 shares (+10,586 vs. pre-transactions), with an additional 2,655 shares held indirectly by spouse.
Sicilia also discloses ≈497 k unvested RSUs from grants in 2021-2024 that were previously omitted from his Form 3; these remain subject to multi-year vesting schedules.
The filing mixes modest open-market sales with a larger option exercise, leaving the officer’s equity stake higher overall while clarifying outstanding equity awards.
Oracle Corp. (ORCL) Form 4 filing: EVP & Chief Accounting Officer Maria Smith reported one transaction dated 08/04/2025. She converted 3,375 restricted stock units (Code “M”), receiving the shares at a $0 exercise price. To satisfy tax withholding, 1,759 shares were automatically disposed (Code “F”) at $244.42 per share. After the transactions, Smith’s direct beneficial ownership stands at 42,423 common shares.
The RSUs vest in four equal annual instalments beginning on the grant’s first anniversary. No open-market purchases or discretionary sales were disclosed; all dispositions relate to tax withholding. The filing involves routine equity compensation activity and does not amend prior disclosures.